Current Trials Open to Enrollment

Adult Trials:

A 6-week trial of an investigational medication given IV as an add-on treatment for Major Depressive Disorder. Individuals 18 to 65 years with Major Depression who are on an antidepressant and have experienced less than a 50% improvement in their depressive symptoms may be eligible. This program has two extension studies available. For more information contact Colleen Figueroa at 813-974-9104, cfiguero@health.usf.edu.

A 12-week study designed to determine the effectiveness of treatment with vortioxetine (Trintellix) on goal achievement after a change in antidepressant medication for the treatment of Major Depressive Disorder (MDD). Individuals 18-65 years with Major Depression who may benefit from a change in antidepressant medication to vortioxetine (Trintellix) may be eligible to enroll. For more information contact Colleen Figueroa at 813-974-9104, cfiguero@health.usf.edu.

A 32-week study of an injectable long-acting antipsychotic medication in individuals with Schizophrenia or Schizoaffective disorder ages 18-64 years. For more information, contact Kathy Smith at 813-974-7006, ksmith5@health.usf.edu.

Additional studies for adults opening soon
Bipolar Disorder – Fall, 2017.

Children & Adolescent Trials:

A 10-week study of an investigational medication for treatment of Major Depression in adolescents, 12-17 years of age. For more information contact Colleen Figueroa at 813-974-9104, cfiguero@health.usf.edu.

A 6-week study with an optional long-term study available, of an investigational medication (SPN-810) for the treatment of Impulsive Aggression in patients with Attention Deficit/Hyperactivity Disorder (ADHD) in conjunction with standard ADHD treatment. Children 6-12 years old may be eligible. For more information contact Colleen Figueroa at 813-974-9104, cfiguero@health.usf.edu.

Additional studies for Children & Adolescents opening soon:
ADHD, ages 4-5 years – Fall, 2017
ADHD, ages 6-17 years – Fall, 2017

Seniors (Age 65+) Trials:

A 24-month study for individuals 65-85 years of age with Mild Cognitive Impairment (MCI) – memory issues. The study is investigating a medical food to determine its effectiveness on cognition and memory. For more information, contact Kathy Smith at 813-974-7006, ksmith5@health.usf.edu.

A 50-week study for individuals’ ages 60 to 90 years, with mild or moderate AD-D who complain of disrupted sleep or multiple awakenings at night along with frequent periods of falling asleep during the day that impact their quality of life. For more information, contact Kathy Smith at 813-974-7006, ksmith5@health.usf.edu.

Additional studies for Seniors (Age 65+) opening soon:

Alzheimer’s disease
Agitation associated with Alzheimer’s disease

Please contact us at 813-974-1404 to learn more about clinical research trials at USF Psychiatry. 
All study related visits, procedures, and study-medications are provided.